Fig. 2From: Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumorsOverall patient satisfaction with treatment at baseline, day 14, and day 28. a Includes responses of “Very satisfied” or “Somewhat satisfied”. bIncludes response of “Definitely recommend” or “Probably recommend”. cIncludes responses of “Very good experience” or “Good experience”. dIncludes responses of “Very satisfied” or “Satisfied.”Back to article page